Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Shares Outstanding (2023 - 2025)

Xenetic Biosciences' Shares Outstanding history spans 6 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 27.12% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $2.3 million, up 27.12%, while the annual FY2025 figure was $2.3 million, 27.12% up from the prior year.
  • Shares Outstanding reached $2.3 million in Q4 2025 per XBIO's latest filing, up from $1.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.8 million in Q2 2023 to a low of $1.5 million in Q1 2023.
  • Average Shares Outstanding over 3 years is $1.8 million, with a median of $1.7 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: tumbled 44.37% in 2024, then increased 27.12% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $1.8 million in 2023, then changed by 0.0% to $1.8 million in 2024, then grew by 27.12% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Shares Outstanding are $2.3 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025).